Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.52 USD
Change Today +0.01 / 0.66%
Volume 610.9K
NEPT On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
Toronto
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

neptune tech & bioressources (NEPT) Snapshot

Open
$1.58
Previous Close
$1.51
Day High
$1.59
Day Low
$1.50
52 Week High
06/19/14 - $2.88
52 Week Low
10/14/14 - $1.11
Market Cap
114.5M
Average Volume 10 Days
208.1K
EPS TTM
$-0.27
Shares Outstanding
75.4M
EX-Date
07/24/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEPTUNE TECH & BIORESSOURCES (NEPT)

Related News

No related news articles were found.

neptune tech & bioressources (NEPT) Related Businessweek News

No Related Businessweek News Found

neptune tech & bioressources (NEPT) Details

Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company is also developing CaPre, which is in Phase II clinical trials for the management of mild to moderate hypertriglyceridemia and severe hypertriglyceridemia, as well as develops and commercializes pharmaceutical applications for cardiovascular and neurological diseases. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.

126 Employees
Last Reported Date: 01/13/15
Founded in 1925

neptune tech & bioressources (NEPT) Top Compensated Officers

Consulting Medical Science Liaison
Total Annual Compensation: C$196.0K
Senior Vice-President of Global Sales
Total Annual Compensation: C$175.2K
Compensation as of Fiscal Year 2014.

neptune tech & bioressources (NEPT) Key Developments

Neptune Technologies & Bioressources, Inc. Provides Revenue Guidance for the Fourth Quarter Ended February 28, 2015

Neptune Technologies & Bioressources, Inc. provided revenue guidance for the fourth quarter ended February 28, 2015, For the quarter, the company expects revenues to be approximately $4.0 million.

Neptune Technologies & Bioressources, Inc., Q4 2015 Guidance/Update Call, Apr 30, 2015

Neptune Technologies & Bioressources, Inc., Q4 2015 Guidance/Update Call, Apr 30, 2015

Neptune Technologies & Bioressources, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 04:30 PM

Neptune Technologies & Bioressources, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 04:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Andre Godin, Chief Financial Officer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEPT:US $1.52 USD +0.01

NEPT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apator SA 44.60 PLN +0.60
Badger Meter Inc $62.54 USD -0.47
Enzymotec Ltd $8.99 USD +0.19
Itron Inc $35.27 USD -0.43
Targeted Medical Pharma Inc $0.20 USD 0.00
View Industry Companies
 

Industry Analysis

NEPT

Industry Average

Valuation NEPT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.0x
Price/Book 2.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit www.neptunebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.